Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China
- PMID: 26351633
- PMCID: PMC4550772
- DOI: 10.1155/2015/419392
Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China
Abstract
Objectives: Several species of rapidly growing mycobacteria (RGM) are now recognized as human pathogens. However, limited data on effective drug treatments against these organisms exists. Here, we describe the species distribution and drug susceptibility profiles of RGM clinical isolates collected from four southern Chinese provinces from January 2005 to December 2012.
Methods: Clinical isolates (73) were subjected to in vitro testing with 31 antimicrobial agents using the cation-adjusted Mueller-Hinton broth microdilution method. The isolates included 55 M. abscessus, 11 M. fortuitum, 3 M. chelonae, 2 M. neoaurum, and 2 M. septicum isolates.
Results: M. abscessus (75.34%) and M. fortuitum (15.07%), the most common species, exhibited greater antibiotic resistance than the other three species. The isolates had low resistance to amikacin, linezolid, and tigecycline, and high resistance to first-line antituberculous agents, amoxicillin-clavulanic acid, rifapentine, dapsone, thioacetazone, and pasiniazid. M. abscessus and M. fortuitum were highly resistant to ofloxacin and rifabutin, respectively. The isolates showed moderate resistance to the other antimicrobial agents.
Conclusions: Our results suggest that tigecycline, linezolid, clofazimine, and cefmetazole are appropriate choices for M. abscessus infections. Capreomycin, sulfamethoxazole, tigecycline, clofazimine, and cefmetazole are potentially good choices for M. fortuitum infections. Our drug susceptibility data should be useful to clinicians.
Similar articles
-
Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.BMC Infect Dis. 2017 Mar 7;17(1):197. doi: 10.1186/s12879-017-2298-8. BMC Infect Dis. 2017. PMID: 28270102 Free PMC article.
-
Rapidly growing mycobacteria in Singapore, 2006-2011.Clin Microbiol Infect. 2015 Mar;21(3):236-41. doi: 10.1016/j.cmi.2014.10.018. Epub 2014 Nov 4. Clin Microbiol Infect. 2015. PMID: 25658536
-
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.Int J Antimicrob Agents. 2010 Apr;35(4):400-4. doi: 10.1016/j.ijantimicag.2009.12.008. Int J Antimicrob Agents. 2010. PMID: 20138481
-
Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.Int J Mycobacteriol. 2021 Jul-Sep;10(3):293-300. doi: 10.4103/ijmy.ijmy_110_21. Int J Mycobacteriol. 2021. PMID: 34494569 Review.
-
Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand.J Med Assoc Thai. 2005 Aug;88(8):1153-62. J Med Assoc Thai. 2005. PMID: 16404850 Review.
Cited by
-
Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.PLoS One. 2018 Nov 29;13(11):e0208053. doi: 10.1371/journal.pone.0208053. eCollection 2018. PLoS One. 2018. PMID: 30496270 Free PMC article.
-
In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.Biomed Res Int. 2018 Dec 30;2018:4902941. doi: 10.1155/2018/4902941. eCollection 2018. Biomed Res Int. 2018. PMID: 30687747 Free PMC article.
-
Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents.Biomed Res Int. 2017;2017:1584658. doi: 10.1155/2017/1584658. Epub 2017 Apr 20. Biomed Res Int. 2017. PMID: 28512635 Free PMC article.
-
Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates.Front Microbiol. 2017 Aug 15;8:1539. doi: 10.3389/fmicb.2017.01539. eCollection 2017. Front Microbiol. 2017. PMID: 28861054 Free PMC article.
-
Evaluation of crystal violet decolorization assay and resazurin microplate assay for antimycobacterial screening.Heliyon. 2019 Aug 28;5(8):e02263. doi: 10.1016/j.heliyon.2019.e02263. eCollection 2019 Aug. Heliyon. 2019. PMID: 31497667 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical